Working… Menu

A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors (NKTR-214)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02869295
Recruitment Status : Completed
First Posted : August 16, 2016
Last Update Posted : November 1, 2018
Information provided by (Responsible Party):
Nektar Therapeutics

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : October 31, 2018
Actual Study Completion Date : October 31, 2018
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 May 2, 2021
May 24, 2021
2 June 14, 2021